Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Michael Seiberling, MD
Woman and Man Max 99 years
Michael Seiberling, MD
Update Il y a 4 ans
A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2009/2010 Influenza Virus Strains for the Northern Hemisphere
This study is to assess whether the Northern Hemisphere 2009/2010 season influenza vaccine Inflexal V fulfills the EMEA requirements for re-registration of influenza vaccines.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Michael Seiberling, MD
Update Il y a 4 ans
Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains
The study is to assess whether the influenza vaccine Inflexal V for season 2012/2013 fulfills the EMA requirements for re-registration of influenza vaccines.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Michael Seiberling, MD
Update Il y a 4 ans
First Time in Man Study of Finafloxacin Hydrochloride
The purpose of this study is to study the safety of single doses and multiple doses of Finafloxacin hydrochloride in healthy volunteers. The level of Finafloxacin hydrochloride will be mea...
Country
Switzerland
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Michael Seiberling, MD
Update Il y a 4 ans
A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551)
The intent of this study is to demonstrate that single doses of the Final Market Image (FMI) ezetimibe/atorvastatin 10mg/10mg and 10mg/80mg fixed dose combination (FDC) tablets are bioequi...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Michael Seiberling, MD
Update Il y a 4 ans
Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers
The purpose of this study is to assess the humoral immune response and safety of the parenteral formulation of the 2010/2011-season virosomal subunit influenza vaccine Inflexal V using two...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Michael Seiberling, MD
Update Il y a 4 ans
A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere
A study to assess whether the Northern Hemisphere 2008/2009 season influenza vaccine Inflexal V fulfills the EMEA requirements for re-registration of influenza vaccines
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Michael Seiberling, MD
Update Il y a 4 ans
Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers
The purpose of this study is to assess the humoral immune response and safety of the parenteral formulation of the 2010/2011-season virosomal subunit influenza vaccine Inflexal V using two...
Country
Switzerland
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Michael Seiberling, MD
Update Il y a 4 ans
A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere
A study to assess whether the Northern Hemisphere 2010/2011 season influenza vaccine Inflexal V fulfills the EMEA requirements for re-registration of influenza vaccines
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Michael Seiberling, MD
Update Il y a 4 ans
Safety, Tolerability and PK of a Single iv Infusion of 10, 40, and 80 µg/kg XG-102 Administered to Healthy Volunteers
The objective of the study is to investigate safety, tolerability, and pharmacokinetics of XG-102 following iv infusion of single escalating dose of 10, 40, and 80 µg/kg XG-102 to healthy ...
Country
None
organs
None
Specialty
None
Closed trial
More information